PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 87 filers reported holding PAIN THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,546,000 | -4.7% | 706,121 | -2.9% | 0.06% | -5.1% |
| Q1 2016 | $1,622,000 | +19.4% | 727,261 | -6.3% | 0.06% | +25.5% |
| Q4 2015 | $1,358,000 | +121.5% | 775,961 | +131.6% | 0.05% | +147.4% |
| Q3 2015 | $613,000 | +5.0% | 335,013 | -0.8% | 0.02% | +11.8% |
| Q2 2015 | $584,000 | -10.7% | 337,740 | -2.4% | 0.02% | -10.5% |
| Q1 2015 | $654,000 | -6.3% | 346,080 | +0.7% | 0.02% | -5.0% |
| Q4 2014 | $698,000 | -52.3% | 343,660 | -8.2% | 0.02% | -55.6% |
| Q3 2014 | $1,464,000 | -32.5% | 374,493 | -0.7% | 0.04% | -28.6% |
| Q2 2014 | $2,168,000 | -11.4% | 377,113 | -15.3% | 0.06% | -4.5% |
| Q1 2014 | $2,447,000 | +130.0% | 444,983 | +103.2% | 0.07% | +144.4% |
| Q4 2013 | $1,064,000 | +174.9% | 218,983 | +54.0% | 0.03% | +170.0% |
| Q3 2013 | $387,000 | +46.0% | 142,220 | +18.6% | 0.01% | +25.0% |
| Q2 2013 | $265,000 | – | 119,960 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
| SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
| GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
| AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
| Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
| Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
| Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
| Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
| TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |